Does This Metric Tell Investors All They Need to Know About Gilead Sciences?The Motley Fool • 10/18/20
Study finds remdesivir, hydroxychloroquine have 'little' impact on mortality in COVID-19 patientsMarket Watch • 10/16/20
European CHMP Adopts Positive Opinion for Kite's KTE-X19 for the Treatment of Relapsed or Refractory Mantle Cell LymphomaBusiness Wire • 10/16/20
Gilead Sciences to Release Third Quarter 2020 Financial Results on Wednesday, October 28, 2020Business Wire • 10/14/20
Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for Immunomedics Tender OfferBusiness Wire • 10/14/20
Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative ColitisBusiness Wire • 10/12/20